Financial Markets Conduct Act 2013

Dealing in financial products on markets - Purposes, overview, and interpretation - Certain derivatives treated as being quoted financial products of listed issuer

233: Certain derivatives treated as being quoted financial products of listed issuer

You could also call this:

"Derivatives based on listed company products are treated like the company's products"

Illustration for Financial Markets Conduct Act 2013

When you are dealing with a derivative, you need to think about what it is based on. If the underlying thing is a quoted financial product of a company that is listed, you must treat the derivative as a quoted financial product of that company. This applies even if the derivative itself is not quoted. You can find more information about this in subpart 2.

You should note that this rule does not apply in certain situations, such as those covered in subpart 5.

You can also look at section 275 and section 298 for more details about how derivatives work and what information people need to share about them.

This text is automatically generated. It might be out of date or be missing some parts. Find out more about how we do this.

This page was last updated on 15 July 2025

View the original legislation for this page at https://legislation.govt.nz/act/public/1986/0120/latest/link.aspx?id=DLM4091291.

Topics:

Money and consumer rights > Banking and loansBusiness > Industry rulesBusiness > Fair trading

232: Meaning of generally available to the market, or

"What 'generally available to the market' means: information investors can easily find and use."

234: Meaning of information insider, inside information, and adviser, or

"What it means to have secret company information or be an adviser"

Part 5Dealing in financial products on markets
Purposes, overview, and interpretation: Certain derivatives treated as being quoted financial products of listed issuer

233Certain derivatives treated as being quoted financial products of listed issuer

If the underlying of a derivative is a quoted financial product of a listed issuer, the derivative must, for the purposes of this subpart and subpart 2, be treated as being a quoted financial product of the listed issuer (whether the derivative is quoted or not).
Subsection (1) does not apply in relation to subpart 5.
See also section 275 (which treats a person as holding financial products where the person has a relevant interest in certain derivatives) and section 298 (which relates to the disclosure of relevant interests and dealings in relevant interests by directors and senior managers).